The global molecular imaging market is estimated to be USD 6,750.1 million in 2021 and is expected to witness a CAGR of 7.84% during the forecast period

Getty Images


July 11, 2022 — The "Molecular Imaging Market, by Application (Cancer, Heart Disease, Brain Disorder), by Technology (Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy), by End User (Hospital, Diagnostic Imaging Centres), and by Region - and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. 

The global molecular imaging market is estimated to be USD 6,750.1 million in 2021 and is expected to witness a CAGR of 7.84% during the forecast period. 

Elderly population in emerging countries such as China and India, the adoption and advancement in technologies such as PET/CT, non-ionizing imaging techniques, and growing demand for efficient and accurate imaging systems for better and effective diagnoses of diseases are driving the global market. However, continuous improvement and innovation in molecular imaging technologies and high cost of the technologies are expected to hinder the global molecular imaging market growth. 

By Technology 

On the basis of technology, the global market is segmented into gamma cameras, single-photon emission computed tomography (SPECT), positron emission tomography (PET), magnetic resonance spectroscopy, optical imaging, and molecular ultrasound imaging. A positron emission tomography (PET) is a non-invasive and simple technology. It delivers improved imaging data and increases patient convenience by decreasing the scanning session count, thus PET technology dominates the global market. PET as an imaging method depends on its ability to discover chronic diseases at early stages. 

By Application 

On the basis of application, the global market is segmented into cancer, heart disease, brain disorder, gastrointestinal disorder, lung disorder, bone disorder, and others. Cancer segment accounted for the largest revenue share in the global market in 2021. Increasing occurrence of various chronic diseases such as cancer and other genetic disorders are propelling demand for early disease diagnosis eventually driving the medical imaging market growth. 

By End User 

On the basis of end-user, the market is categorized into hospitals, diagnostic imaging centers, and others. Hospitals & clinics accounted for the largest market share the market in 2021. The factors including well-resourced operating & surgical rooms, attendance of skilled healthcare professionals, and improved health coverage for healthcare services from various private and group insurance, among others, are accountable for the market dominance of hospitals. 

Regional Insights 

North America dominated the global market in 2021 and is projected to maintain its domination during the forecast period. The reason for this market share is the increase owing to increasing healthcare aid from government and private organizations to develop technologically advanced medical systems that will help in fulfilling the demand of increasing population suffering from various diseases. 

Asia Pacific market is projected to grow at a fastest CAGR during the forecast period. Trends such as growing senior population, urbanization, prevalence of chronic diseases, and demand for improved diagnostic care in the region expected to boost the regional growth. 

For more information: ://www.researchandmarkets.com/r/hfluyd 

 


Related Content

News | Radiation Therapy

September 28, 2023 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the ...

Time September 28, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | By Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | SNMMI

September 18, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), as a professional society ...

Time September 18, 2023
arrow
News | PET-CT

September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...

Time September 08, 2023
arrow
News | PET-CT

September 7, 2023 — The groundbreaking AURA 10 specimen imager by Belgian MedTech pioneer XEOS has been cleared by the ...

Time September 07, 2023
arrow
Feature | PET Imaging

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

Time September 05, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 31, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time August 31, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a ...

Time August 29, 2023
arrow
Subscribe Now